REGEN-COV was given emergency use authorization by the FDA to treat mild-to-moderate coronavirus disease 2019 (COVID-19) or prevent COVID-19 infections in people who were exposed to the virus. REGEN-COV is given through an injection, and there are specific criteria people need to meet in order to receive the medication.
Treatment of mild-to-moderate COVID-19 infections in people aged 12 years and older who are at high risk of developing severe COVID-19
Prevention of COVID-19 infections in people aged 12 years and older who were exposed to the COVID-19 virus and are at high risk of developing severe COVID-19 (post-exposure prevention)
REGEN-COV is a combination of two monoclonal antibodies, casirivimab and imdevimab. Casirivimab and imdevimab bind to receptors on the COVID-19 virus, which blocks the virus from attaching to receptors in your body. This can help treat and prevent COVID-19 symptoms.
Source:Â FDA
One of the first treatments available for COVID-19
Can be used to treat or prevent COVID-19 infections
If using the medication for the treatment of COVID-19, you usually only need one injection.
Need to meet specific criteria in order to receive the medication
Can only be used in people aged 12 years and older
If using the medication for post-exposure prevention, you might need more than one dose.
Cannot be used for people with severe COVID-19
REGEN-COV is administered by a healthcare provider. Your provider will monitor you for any side effects while you receive the medication and for at least 1 hour afterwards.
If you're receiving REGEN-COV through an IV infusion, the infusion can take 20 to 50 minutes. Your provider will decide how long your infusion will take.
If you're receiving REGEN-COV through an injection under your skin, the dose will be given in multiple injections in separate areas on your body, all around the same time.
If you're receiving REGEN-COV for post-exposure prevention, you might need additional doses of the medication for protection. Your provider will decide if multiple doses are needed and if so, they will be given to you once a month.
It's important that you continue to self-isolate and practice CDC-recommended safety measures to protect yourself and others from either getting or spreading the COVID-19 virus.
Receiving REGEN-COV for post-exposure prevention of COVID-19 isn't a replacement for vaccination against the virus. Talk to your provider about when the best time it is for you to get vaccinated against COVID-19 after you've received this medication.
Because REGEN-COV is still being studied, not all of the side effects are known and you can develop serious or unexpected side effects. Known side effects of the medication include allergic reactions, worsening COVID-19 symptoms, or reactions at the IV infusion or injection site. Contact your healthcare provider if develop any symptoms that concern you.
REGEN-COV can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Your COVID-19 symptoms can get worse after you receive REGEN-COV. You can experience symptoms such as fever, trouble breathing, tiredness, confusion, and changes in your heart rate or heart rhythm. Talk to your healthcare provider or get medical help if you develop any of these symptoms because they might require hospitalization. Because REGEN-COV is such a new treatment, it's unknown if these symptoms are caused by the medication or the natural development of the COVID-19 virus itself.
Risk factors: Hospitalized due to COVID-19 | Requiring new or more oxygen treatment due to COVID-19
REGEN-COV might not be beneficial and might cause worse health outcomes for people with severe COVID-19 infections. This includes people who are hospitalized with COVID-19 and need help breathing (e.g., people on a ventilator or using high-flow oxygen). Because of this risk, REGEN-COV isn't authorized to be used in people who are hospitalized with COVID-19 or people who require new or more oxygen treatment because of their COVID-19 infection.
REGEN-COV is administered by a healthcare provider. The typical dose of REGEN-COV is 600 mg/600 mg (casirivimab/imdevimab) given through an injection in your veins (intravenous or IV infusion) or under your skin (subcutaneous injection). If you're taking REGEN-COV to treat COVID-19, it's recommended that the medication be given through an IV infusion rather than through an injection under your skin.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.